Statin use in diabetes patients without known heart disease
Part of Hormones & metabolism clinical trials.
This trial tests whether a common cholesterol-lowering medicine (a statin) helps people with diabetes who do not already have heart disease. If you have diabetes but no history of heart problems, taking a statin might reduce your future risk of heart attack or stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have diabetes
- You have never been told you have heart disease, or had a heart attack, stroke, or blocked arteries (atherosclerotic cardiovascular disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two approaches to lower cholesterol in people aged 70+ with type 2 diabetes: a moderate statin dose versus adjusting treatment to reach a personalized LDL-C target. It aims to find which strategy better prevents heart problems.
This study tests if taking a statin along with an SGLT2 inhibitor (a diabetes drug that also helps the heart) works better for people with heart disease caused by blocked arteries. The goal is to improve heart function with this combination therapy.
This study compares two different ways of lowering cholesterol: a moderate statin (pitavastatin) plus another drug (ezetimibe) versus a stronger statin alone. The goal is to see which approach is safer regarding the risk of developing new diabetes.
This study looks at whether taking a low- to moderate-dose statin can prevent first-time heart and stroke problems in people age 70 and older. It may help you lower “bad cholesterol” (LDL) and see if that leads to fewer heart events over time.
This trial tests how certain statin drugs (medicines that lower cholesterol) affect heart and blood vessel function in healthy people. If you are healthy, you may help researchers understand how these drugs work.
This trial compares two cholesterol-lowering approaches in people with prediabetes to see which one is less likely to lead to new-onset diabetes. It may help you choose a safer medication plan if you need strong cholesterol treatment to prevent future heart problems.
Hear when a new Diabete Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.